MPP Strikes Landmark Licensing Deal With Novartis On Nilotinib

Agreement On Tasigna Generics Represents First Such Deal For A Cancer Medicine

 
• By David Wallace
  
Novartis logo building
Novartis has signed a voluntary licensing deal with the MPP for nilotinib • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet